Malaria

Kristina Krohn; William Stauffer

doi:10.1007/978-3-030-47668-7_8

Malaria

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The World Health Organization (WHO) estimated 219 million cases of malaria and 435,000 deaths from malaria in 2017. Displaced people suffer additional exposures to malaria and have additional barriers to receiving appropriate care, increasing their risk of suffering and dying from malaria. Some refugees carry subclinical infection and may not present to a health-care provider with signs and symptoms for 3 months or more after they arrive in the United States. While P. falciparum causes most malaria deaths, this chapter further explains the four main species of malaria and their geographic distribution, clinical presentations, and treatments, including recommended prophylactic treatment of refugees. Although malaria is found throughout the tropics, the Centers for Disease Control and Prevention (CDC) recommends that only refugees from highly endemic areas in sub-Saharan Africa should receive prophylactic post-arrival treatment. This chapter outlines presumptive overseas treatment and recommendations for domestic screening.

Original language	English (US)
Title of host publication	Refugee Health Care
Subtitle of host publication	An Essential Medical Guide, Second Edition
Publisher	Springer International Publishing
Pages	119-126
Number of pages	8
ISBN (Electronic)	9783030476687
ISBN (Print)	9783030476670
DOIs	https://doi.org/10.1007/978-3-030-47668-7_8
State	Published - Jan 1 2020

Bibliographical note

Publisher Copyright:
© Springer Nature Switzerland AG 2020.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Africa
Antimalarials
Artemether-lumefantrine
Artemisinin-based therapy
Atovaquone-proguanil
Diagnosis
Hyperendemic
Malaria
Migrant
Plasmodium falciparum
Plasmodium malariae
Plasmodium ovale
Plasmodium vivax
Polymerase chain reaction
Prophylactic treatment
Rapid antigen test
Refugees
Sub-Saharan Africa
Thick-and-thin smear
Treatment

Publisher link

10.1007/978-3-030-47668-7_8

Find It

Find It at U of M Libraries

Cite this

@inbook{745b77b4871740018d56836d56c46b50,

title = "Malaria",

abstract = "The World Health Organization (WHO) estimated 219 million cases of malaria and 435,000 deaths from malaria in 2017. Displaced people suffer additional exposures to malaria and have additional barriers to receiving appropriate care, increasing their risk of suffering and dying from malaria. Some refugees carry subclinical infection and may not present to a health-care provider with signs and symptoms for 3 months or more after they arrive in the United States. While P. falciparum causes most malaria deaths, this chapter further explains the four main species of malaria and their geographic distribution, clinical presentations, and treatments, including recommended prophylactic treatment of refugees. Although malaria is found throughout the tropics, the Centers for Disease Control and Prevention (CDC) recommends that only refugees from highly endemic areas in sub-Saharan Africa should receive prophylactic post-arrival treatment. This chapter outlines presumptive overseas treatment and recommendations for domestic screening.",

keywords = "Africa, Antimalarials, Artemether-lumefantrine, Artemisinin-based therapy, Atovaquone-proguanil, Diagnosis, Hyperendemic, Malaria, Migrant, Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale, Plasmodium vivax, Polymerase chain reaction, Prophylactic treatment, Rapid antigen test, Refugees, Sub-Saharan Africa, Thick-and-thin smear, Treatment",

author = "Kristina Krohn and William Stauffer",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2020.",

year = "2020",

month = jan,

day = "1",

doi = "10.1007/978-3-030-47668-7\_8",

language = "English (US)",

isbn = "9783030476670",

pages = "119--126",

booktitle = "Refugee Health Care",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Malaria

AU - Krohn, Kristina

AU - Stauffer, William

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2020.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - The World Health Organization (WHO) estimated 219 million cases of malaria and 435,000 deaths from malaria in 2017. Displaced people suffer additional exposures to malaria and have additional barriers to receiving appropriate care, increasing their risk of suffering and dying from malaria. Some refugees carry subclinical infection and may not present to a health-care provider with signs and symptoms for 3 months or more after they arrive in the United States. While P. falciparum causes most malaria deaths, this chapter further explains the four main species of malaria and their geographic distribution, clinical presentations, and treatments, including recommended prophylactic treatment of refugees. Although malaria is found throughout the tropics, the Centers for Disease Control and Prevention (CDC) recommends that only refugees from highly endemic areas in sub-Saharan Africa should receive prophylactic post-arrival treatment. This chapter outlines presumptive overseas treatment and recommendations for domestic screening.

AB - The World Health Organization (WHO) estimated 219 million cases of malaria and 435,000 deaths from malaria in 2017. Displaced people suffer additional exposures to malaria and have additional barriers to receiving appropriate care, increasing their risk of suffering and dying from malaria. Some refugees carry subclinical infection and may not present to a health-care provider with signs and symptoms for 3 months or more after they arrive in the United States. While P. falciparum causes most malaria deaths, this chapter further explains the four main species of malaria and their geographic distribution, clinical presentations, and treatments, including recommended prophylactic treatment of refugees. Although malaria is found throughout the tropics, the Centers for Disease Control and Prevention (CDC) recommends that only refugees from highly endemic areas in sub-Saharan Africa should receive prophylactic post-arrival treatment. This chapter outlines presumptive overseas treatment and recommendations for domestic screening.

KW - Africa

KW - Antimalarials

KW - Artemether-lumefantrine

KW - Artemisinin-based therapy

KW - Atovaquone-proguanil

KW - Diagnosis

KW - Hyperendemic

KW - Malaria

KW - Migrant

KW - Plasmodium falciparum

KW - Plasmodium malariae

KW - Plasmodium ovale

KW - Plasmodium vivax

KW - Polymerase chain reaction

KW - Prophylactic treatment

KW - Rapid antigen test

KW - Refugees

KW - Sub-Saharan Africa

KW - Thick-and-thin smear

KW - Treatment

UR - https://www.scopus.com/pages/publications/85166068933

UR - https://www.scopus.com/pages/publications/85166068933#tab=citedBy

U2 - 10.1007/978-3-030-47668-7_8

DO - 10.1007/978-3-030-47668-7_8

M3 - Chapter

AN - SCOPUS:85166068933

SN - 9783030476670

SP - 119

EP - 126

BT - Refugee Health Care

PB - Springer International Publishing

ER -

Malaria

Abstract

Bibliographical note

UN SDGs

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this